tiprankstipranks
Advertisement
Advertisement

HK:1167 Stock Latest News

Jacobio Pharmaceuticals Launches HK$100 Million Share Buyback Plan
Company AnnouncementsJacobio Pharmaceuticals Launches HK$100 Million Share Buyback Plan
7d ago
1167
Jacobio Shareholders Back All Resolutions at 2026 AGM, Renewing Capital Mandates
PremiumCompany Announcements
Jacobio Shareholders Back All Resolutions at 2026 AGM, Renewing Capital Mandates
10d ago
1167
Jacobio Boosts Share Buybacks and Liquidity as Oncology Pipeline Advances
PremiumCompany Announcements
Jacobio Boosts Share Buybacks and Liquidity as Oncology Pipeline Advances
27d ago
1167
Jacobio Pharmaceuticals Sets 2026 AGM, Seeks Fresh Share Issuance Mandate
PremiumCompany Announcements
Jacobio Pharmaceuticals Sets 2026 AGM, Seeks Fresh Share Issuance Mandate
2M ago
1167
Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
PremiumCompany Announcements
Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
3M ago
1167
Jacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
PremiumRatingsJacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
3M ago
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
Premium
Company Announcements
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
3M ago
1167
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
4M ago
1167
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
PremiumCompany Announcements
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
5M ago
1167
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
PremiumCompany Announcements
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
5M ago
1167
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
PremiumCompany Announcements
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
6M ago
1167
Jacobio Pharmaceuticals Secures RMB125 Million to Advance Oncology Pipeline
PremiumCompany Announcements
Jacobio Pharmaceuticals Secures RMB125 Million to Advance Oncology Pipeline
6M ago
1167
Jacobio’s KRAS G12C and SHP2 Therapy Shows Promising Results in Clinical Trials
PremiumCompany AnnouncementsJacobio’s KRAS G12C and SHP2 Therapy Shows Promising Results in Clinical Trials
7M ago
1167
Jacobio Pharmaceuticals Appoints Dr. Andrea Wang-Gillam as Co-CEO to Boost Global Strategy
Premium
Company Announcements
Jacobio Pharmaceuticals Appoints Dr. Andrea Wang-Gillam as Co-CEO to Boost Global Strategy
7M ago
1167
Jacobio Pharmaceuticals Launches Promising Study on JAB-23E73 for KRAS-Altered Tumors
Premium
Company Announcements
Jacobio Pharmaceuticals Launches Promising Study on JAB-23E73 for KRAS-Altered Tumors
8M ago
1167
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-23E73 Study
PremiumCompany Announcements
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-23E73 Study
8M ago
1167
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
PremiumCompany Announcements
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
8M ago
1167
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
PremiumCompany Announcements
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
8M ago
1167
Jacobio Pharmaceuticals Advances Strategic Focus with Capital Increase and Equity Transfer
PremiumCompany Announcements
Jacobio Pharmaceuticals Advances Strategic Focus with Capital Increase and Equity Transfer
8M ago
1167
Jacobio Pharmaceuticals Announces Shareholding Changes and Share Repurchase Updates
PremiumCompany AnnouncementsJacobio Pharmaceuticals Announces Shareholding Changes and Share Repurchase Updates
9M ago
1167
Jacobio Pharmaceuticals Sees Increase in Concert Party Shareholdings
Premium
Company Announcements
Jacobio Pharmaceuticals Sees Increase in Concert Party Shareholdings
9M ago
1167
Jacobio Pharmaceuticals Reports Significant Progress in Oncology Pipeline for H1 2025
Premium
Company Announcements
Jacobio Pharmaceuticals Reports Significant Progress in Oncology Pipeline for H1 2025
10M ago
1167

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >